MFS
ELDN icon

MSI Financial Services’s Eledon Pharmaceuticals ELDN Stock Holding History

MSI Financial Services’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$0 Hold
2
– – ﹤0.01% 3868
2016
Q3 		$0 Hold
2
– – ﹤0.01% 3905
2016
Q2 		$2K Hold
2
– – ﹤0.01% 3493
2016
Q1 		$2K Buy
+2
New +$1.96K ﹤0.01% 3514

Other funds holding ELDN

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MSI Financial Services's ELDN Position: Q4 2016 in Review

MSI Financial Services held its Eledon Pharmaceuticals (ELDN) position steady in Q4 2016 at 2 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #3868.

MSI Financial Services first reported a position in ELDN in Q1 2016 and has held it in 4 quarters since. The position peaked at $2K in Q2 2016. 42 funds tracked by Wall St. Rank hold ELDN as of Q4 2016.

  • MSI Financial Services held 2 shares of Eledon Pharmaceuticals worth $0 as of Q4 2016.
  • MSI Financial Services left its Eledon Pharmaceuticals share count unchanged in Q4 2016.
  • Eledon Pharmaceuticals made up ﹤0.01% of MSI Financial Services's portfolio in Q4 2016, its #3868 holding.
  • MSI Financial Services first reported a position in Eledon Pharmaceuticals in Q1 2016 and has held it in 4 quarters since.
  • MSI Financial Services's Eledon Pharmaceuticals position peaked at $2K in Q2 2016.
  • 42 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.